Capital Advisors Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Capital Advisors Wealth Management, LLC
- $556 Million
- Q4 2024
A detailed history of Capital Advisors Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Advisors Wealth Management, LLC holds 2,864 shares of GILD stock, worth $336,262. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,864
Previous 2,544
12.58%
Holding current value
$336,262
Previous $213,000
23.94%
% of portfolio
0.05%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,099Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13.6 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.42 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$7.09 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.8 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $147B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...